You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Study finds primary-care doctors often overlook prostate cancer risk in Black men
- 2. Development and validation of a prostate cancer risk prediction model for the elevated PSA population
- 3. The predictive value of PSMA PET/CT in determining pathological upgrading of prostate cancer: A pooling up analysis
- 4. New hurdle seen to prostate screening: primary-care docs
- 5. SEPTEMBER IS PROSTATE CANCER AWARENESS MONTH: PROCURE PROTON THERAPY CENTER ENCOURAGES MEN TO LEARN ABOUT THEIR OPTIONS
- 6. Orthocell's Remplir used in nerve-sparing prostate cancer surgery
- 7. Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
- 8. Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma
- 9. The paradoxical role of stem cells in osteosarcoma: from pathogenesis to therapeutic breakthroughs
- 10. ‘I was told I had two weeks to live' – why are so many young, fit, non-smoking women getting lung cancer?
Last updated at 10:40 GMT
Hot News Makers
Health/Pharma Companies
-
122360.63
-
15583.21
-
13911.78
-
11825.01
-
11100.62
-
7395.48
-
7209.68
-
6535.88
-
6501.30
-
6458.21
Drugs, Treatments, Trials
-
14919.91
-
14135.67
-
6265.15
-
5892.54
-
5144.35
-
4191.93
-
2959.53
-
2420.35
-
2023.45
-
1894.93
Last updated at 10:10 GMT
